Breakpoints
A podcast by Society of Infectious Diseases Pharmacists - Venerdì
124 Episodio
-
#64 – Putting the Fun in Fungi: A Fun-guide to New Antifungals
Pubblicato: 23/09/2022 -
#63 – I Never Metapneumovirus that Required Antibiotics: Prevention & Treatment of Common Respiratory Viruses in Adults
Pubblicato: 16/09/2022 -
#62 – Novel TheraPOOtics: The Microbiome, C. difficile, and LBPs
Pubblicato: 26/08/2022 -
#61 – Dosing Consult: Linezolid Therapeutic Drug Monitoring
Pubblicato: 19/08/2022 -
#60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID
Pubblicato: 22/07/2022 -
#59 – Resistance in Pseudomonas aeruginosa: Pearls and Perils
Pubblicato: 15/07/2022 -
#58 – We're Gonorrhea-valuate: Updates and Implementation of STI Treatment Guidelines
Pubblicato: 24/06/2022 -
#57 – Dosing Consult: Ceftriaxone
Pubblicato: 27/05/2022 -
#56 – Empiric Escalation: Gazing into the Crystal Ball for Multidrug-Resistant Gram-Negatives
Pubblicato: 15/04/2022 -
#55 – One World: Global Perspectives in Antimicrobial Stewardship
Pubblicato: 25/03/2022 -
#54 – Connecting with our Colleagues: COVID-19 Treatments in Community Pharmacies
Pubblicato: 18/03/2022 -
#53 – Abscessus and fortuitum and avium, Oh My!: Updates and Controversies in NTM Management
Pubblicato: 18/02/2022 -
#52 – A Conversation with the Authors of IDSA Guidance on Treatment of AmpC, CRAB, and Stenotrophomonas
Pubblicato: 28/01/2022 -
#51 – A Conversation with the Authors of IDSA Guidance on Treatment of ESBL, CRE, and DTR Pseudomonas
Pubblicato: 21/01/2022 -
#50 – Moving to the Algo-rhythm of IDWeek 2021: Highlights in SoMe and ASP
Pubblicato: 17/12/2021 -
#49 – A PGY-What Now? A Primer on ID Pharmacy Fellowships
Pubblicato: 03/12/2021 -
#48 – Aligning Goals: Antibiotics in End of Life Care
Pubblicato: 19/11/2021 -
#47 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 2
Pubblicato: 29/10/2021 -
#46 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 1
Pubblicato: 22/10/2021 -
#45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials
Pubblicato: 24/09/2021
The SIDP Podcast